| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 173.53▼ | 173.21▲ | 172.94▲ | 183.70▼ | 168.60▲ |
| MA10 | 173.37▲ | 173.07▲ | 174.01▼ | 171.44▲ | 161.74▲ |
| MA20 | 173.38▲ | 174.42▼ | 177.58▼ | 166.44▲ | 153.73▲ |
| MA50 | 173.38▲ | 182.22▼ | 177.71▼ | 160.73▲ | 149.20▲ |
| MA100 | 174.54▼ | 176.06▼ | 167.40▲ | 154.68▲ | 106.40▲ |
| MA200 | 179.57▼ | 167.07▲ | 165.89▲ | 159.14▲ | 71.34▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.053▲ | 0.252▲ | -0.841▼ | 1.555▲ | 2.272▲ |
| RSI | 51.662▲ | 38.954▼ | 40.573▼ | 54.917▲ | 58.115▲ |
| STOCH | 82.248▲ | 29.339 | 14.785▼ | 75.047 | 64.121 |
| WILL %R | -36.255 | -72.659 | -79.519▼ | -52.036 | -38.990 |
| CCI | 116.446▲ | -30.522 | -55.002 | 44.324 | 168.402▲ |
| ▲ GAP | $BLTE Open Gap Up %2 | Set Alert |
|
Monday, August 24, 2026 01:00 PM
Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have ...
|
|
Wednesday, May 20, 2026 03:06 PM
Belite Bio (NASDAQ:BLTE) said it has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for Tinlarebant in Stargardt disease, while also accelerating preparations ...
|
|
Wednesday, May 20, 2026 03:57 AM
Belite Bio, Inc. (NASDAQ:BLTE) reported first-quarter results on Wednesday that came in ahead of analyst forecasts, with the clinical-stage biotech group posting an adjusted loss per share of -$0.34 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/09/26 | 179.99 | 179.99 | 171.2101 | 173.79 | 143,711 |
| 10/09/26 | 180.27 | 181.225 | 173.00 | 175.07 | 200,254 |
| 09/09/26 | 191.09 | 191.30 | 181.80 | 183.16 | 208,412 |
| 08/09/26 | 192.71 | 198.58 | 187.51 | 192.85 | 571,456 |
| 04/09/26 | 172.77 | 193.88 | 172.77 | 193.61 | 735,495 |
| 03/09/26 | 161.25 | 171.78 | 159.86 | 171.09 | 200,880 |
| 02/09/26 | 157.99 | 163.70 | 157.3325 | 160.66 | 212,681 |
| 01/09/26 | 154.49 | 157.19 | 153.85 | 156.70 | 114,135 |
| 31/08/26 | 150.94 | 158.39 | 150.94 | 155.71 | 146,166 |
| 28/08/26 | 156.75 | 156.75 | 151.15 | 151.72 | 164,772 |
|
|
||||
|
|
||||
|
|